Insulin Resistance and PCOS in Korea: Complete Guide

Insulin Resistance and PCOS in Korea: Complete Guide

PCOS is usually discussed in terms of its most visible symptoms — irregular periods, acne, excess hair growth. But underneath many of these symptoms sits a less visible driver that researchers increasingly consider central to the condition itself: insulin resistance. Understanding this connection changes how PCOS is often treated, since addressing insulin resistance directly can improve not just metabolic health, but the reproductive and skin-related symptoms that first bring many women to a doctor.

This guide covers how insulin resistance and PCOS are connected, why the relationship is more of a cycle than a one-way street, and what treatment approaches specifically target this piece of the condition at clinics in Busan.

What Is Insulin Resistance?

Insulin resistance occurs when the body's cells don't respond normally to insulin, the hormone responsible for moving glucose out of the bloodstream and into cells for energy. When cells resist insulin's signal, the pancreas compensates by producing more insulin to achieve the same effect, leading to elevated insulin levels in the blood, a state called hyperinsulinemia, even when blood sugar itself may still appear normal on standard testing.

How Insulin Resistance and PCOS Are Connected

Current research describes PCOS as involving a self-perpetuating cycle between insulin resistance and hyperandrogenism (elevated androgen levels) — each one tends to worsen the other, creating a loop rather than a simple cause-and-effect relationship.

How Excess Insulin Drives Androgen Excess

Elevated insulin levels directly stimulate the ovaries and adrenal glands to produce more androgens. Insulin also reduces the liver's production of a protein called sex hormone-binding globulin (SHBG), which normally binds to androgens and keeps them less biologically active. With less SHBG available, more free, active androgen circulates in the body, worsening symptoms like acne, excess hair growth, and irregular ovulation.

The "Ovarian Paradox"

One of the more interesting and clinically relevant findings in recent PCOS research is what's sometimes called the ovarian paradox: while many tissues throughout the body become resistant to insulin in PCOS, the ovary itself often remains unusually sensitive to insulin's effects, particularly through a specific signaling pathway. This means insulin can continue driving excess androgen production in the ovary even while the rest of the body struggles to respond to insulin normally — helping explain why PCOS involves both metabolic dysfunction and reproductive symptoms simultaneously.

Signs That May Suggest Insulin Resistance

• Difficulty losing weight despite consistent diet and exercise efforts
• Weight gain concentrated around the abdomen
• Darkened, velvety patches of skin, particularly around the neck, armpits, or groin (acanthosis nigricans)
• Skin tags, particularly in areas of friction
• Intense sugar or carbohydrate cravings
• Fatigue, particularly after meals
• A family history of type 2 diabetes

Insulin resistance can be present in women with PCOS regardless of body weight, meaning it's not exclusive to women who are overweight, even though it does occur more frequently and often more severely in that group.

Why This Connection Matters for Long-Term Health

Beyond its role in driving PCOS symptoms, insulin resistance carries its own longer-term health implications, including a significantly elevated risk of developing type 2 diabetes and cardiovascular risk factors over time. This is one of the more important reasons PCOS management increasingly focuses on metabolic health, not just menstrual regularity or skin symptoms, since addressing insulin resistance may help reduce these longer-term risks alongside improving day-to-day symptoms.

Diagnosis

Insulin resistance isn't always directly measured in routine PCOS evaluation, but several tools can help assess it:

Fasting Glucose and Insulin Levels

Basic blood tests that, combined, can be used to calculate a measure called HOMA-IR (Homeostatic Model Assessment of Insulin Resistance), a commonly used research and clinical tool for estimating insulin resistance.

Oral Glucose Tolerance Test

Measures how the body processes glucose over a couple of hours after a standardized sugary drink, offering a more dynamic picture than a single fasting measurement.

HbA1c

Reflects average blood sugar over the preceding few months and is commonly used as part of broader metabolic screening.

Physical Signs

Acanthosis nigricans and abdominal weight distribution can offer clinical clues supporting a suspicion of insulin resistance alongside laboratory testing.

Treatment Approaches Targeting Insulin Resistance

Metformin

Considered the gold-standard insulin-sensitizing medication for PCOS, metformin works primarily by decreasing glucose production in the liver and improving the body's sensitivity to insulin. It has shown benefits including improved insulin resistance markers, reduced circulating androgens, increased SHBG, and restored menstrual regularity in many women. Its main drawback is a relatively common side effect profile involving gastrointestinal discomfort, nausea, and diarrhea, which affects how well some patients tolerate long-term use.

Inositol (Myo-Inositol and D-Chiro-Inositol)

Inositol has emerged as one of the more well-supported non-prescription options for insulin resistance in PCOS, with meta-analyses showing meaningful improvement in HOMA-IR scores and restoration of spontaneous ovulation, leading to its inclusion in updated international PCOS management guidelines. Interestingly, research suggests the ratio between the two main forms — myo-inositol and D-chiro-inositol — matters considerably, with a roughly 40:1 ratio believed to more closely mirror the body's natural physiological balance, rather than assuming any inositol product will perform equivalently regardless of its specific formulation.

Combination Therapy

Several studies have found that combining metformin with myo-inositol produces synergistic benefits beyond either treatment alone, showing improved menstrual cycle regularity, reduced hyperandrogenic symptoms, and better fertility outcomes in women undergoing ovulation induction. This combined approach is increasingly used in clinical practice for women who need more comprehensive management of the insulin resistance component of PCOS.

Lifestyle Interventions

Diet quality, particularly lower-glycemic eating patterns, and regular exercise remain foundational for improving insulin sensitivity, and are generally recommended alongside, rather than instead of, medication for women with more significant insulin resistance.

Newer and Emerging Treatments

Research into more targeted therapies for the insulin resistance-hyperandrogenism cycle in PCOS continues to evolve, with ongoing investigation into additional insulin-sensitizing approaches and other mechanisms specific to the ovarian paradox described above. This remains an active area of research rather than a settled question, so treatment approaches may continue to expand in coming years.

Choosing Between Metformin and Inositol

Because metformin and inositol work through related but distinct mechanisms, and because metformin's gastrointestinal side effects lead some women to discontinue it, inositol has been studied specifically as an alternative for those who don't tolerate metformin well. Current evidence doesn't necessarily suggest one is universally superior to the other; rather, the choice often comes down to individual tolerance, symptom severity, and whether combination therapy might offer added benefit. This is a decision best made together with a gynecologist familiar with current PCOS treatment guidelines, rather than choosing independently based on general information alone.

Why Choose Busan for Insulin Resistance and PCOS Management

Gynecology clinics in Busan offer comprehensive PCOS evaluation that specifically includes assessment of insulin resistance markers, along with treatment options spanning metformin, inositol, combination therapy, and lifestyle counseling. International patients can access individualized treatment planning that addresses both the metabolic and reproductive dimensions of PCOS together, with English-speaking support available at many international-facing clinics.

Tips for International Patients

• Ask specifically whether insulin resistance testing, such as fasting insulin and glucose or HOMA-IR calculation, is part of your PCOS evaluation
• Mention any signs like acanthosis nigricans, abdominal weight gain, or intense sugar cravings, since these can support a clinical suspicion of insulin resistance
• If considering inositol supplementation, ask about the specific myo-inositol to D-chiro-inositol ratio in the product, since this has been shown to matter for effectiveness
• Discuss your tolerance for metformin's gastrointestinal side effects openly, since this may influence whether inositol or a combination approach is more suitable for you
• Ask how your insulin resistance treatment plan connects to your other PCOS goals, whether that's fertility, acne, or long-term metabolic health

Frequently Asked Questions

Does everyone with PCOS have insulin resistance?

Not universally, but it's very common, and research suggests it occurs regardless of body weight, meaning even women with PCOS who aren't overweight can have significant insulin resistance.

Is metformin or inositol better for PCOS-related insulin resistance?

Both have supporting evidence, and the better choice often depends on individual tolerance and symptom severity rather than one being universally superior. Some women benefit from combining both under medical guidance.

Can insulin resistance cause PCOS symptoms even if my blood sugar is normal?

Yes. Insulin resistance often shows up as elevated insulin levels while blood sugar itself remains within a normal range, especially early on, which is why insulin-specific testing, not just standard glucose testing, can be more revealing.

Why does insulin resistance affect my skin and hair, not just my metabolism?

Elevated insulin stimulates the ovaries and adrenal glands to produce more androgens and reduces a protein that normally keeps androgens less active, which is why insulin resistance contributes directly to symptoms like acne and excess hair growth, not just metabolic changes.

Does treating insulin resistance improve fertility in PCOS?

For many women, yes. Both metformin and inositol have been shown to help restore more regular ovulation, and combination therapy has shown particular benefit for fertility outcomes in some studies.

Does inositol dosage or ratio actually matter?

Emerging research suggests it does — a roughly 40:1 ratio of myo-inositol to D-chiro-inositol is thought to more closely match natural physiological balance, meaning not all inositol products are necessarily equivalent in their effectiveness.

Conclusion

Insulin resistance sits at the center of much of what makes PCOS a complex, multi-system condition rather than simply a reproductive issue, driving both the metabolic risks and many of the more visible symptoms women experience. Treatments targeting this specific mechanism — metformin, inositol, or a combination of both, alongside lifestyle support — offer a genuinely evidence-based path toward improving symptoms across the board, from menstrual regularity to skin and hair changes. Gynecology clinics in Busan can help assess your specific insulin resistance profile and build a treatment plan that addresses this central piece of the PCOS puzzle directly.